# BAHCC1

## Overview
BAHCC1, or BAH domain and coiled-coil containing 1, is a gene that encodes a protein involved in chromatin organization and gene silencing. The protein, characterized by a conserved Bromo-Adjacent Homology (BAH) domain, plays a pivotal role in recognizing and binding to the trimethylation of histone H3 lysine 27 (H3K27me3), a modification associated with gene repression. This interaction is crucial for maintaining a hypoacetylated chromatin state, thereby facilitating transcriptional silencing. BAHCC1 is implicated in various cellular processes, including cell cycle control and differentiation, and is evolutionarily conserved across vertebrate species, underscoring its fundamental biological importance. The protein's interactions with transcriptional co-repressors and chromatin remodeling complexes further highlight its role in regulating gene expression. Clinically, BAHCC1 is associated with oncogenesis, particularly in acute leukemias and melanoma, where its dysregulation contributes to tumorigenicity and poor prognosis (Berico2023Superenhancer; Fan2020BAHCC1).

## Function
The BAHCC1 gene encodes a protein that plays a crucial role in gene silencing through its interaction with the histone modification H3K27me3, a marker associated with gene repression. The BAH domain of BAHCC1 specifically binds to H3K27me3, facilitating the silencing of genes marked by this modification (Fan2020BAHCC1). This interaction is essential for maintaining a hypoacetylated chromatin state, which is necessary for gene silencing. BAHCC1 achieves this by associating with transcriptional co-repressors such as SAP30BP and HDAC1, which help maintain the deacetylated state of target genes (Fan2020BAHCC1).

In healthy human cells, BAHCC1 is localized in the nucleus, where it regulates gene expression programs critical for cell cycle control and differentiation (Fan2020BAHCC1). The protein's role in gene silencing is significant for normal cellular processes, including the regulation of cell proliferation and apoptosis (Fan2020BAHCC1). The evolutionary conservation of the BAH domain across species underscores its fundamental role in cellular processes (Fan2020BAHCC1).

## Clinical Significance
BAHCC1 is implicated in various cancers due to its role in gene silencing and chromatin regulation. In acute leukemias, such as acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), BAHCC1 is often overexpressed, correlating with poor prognosis and genetic abnormalities like MLL rearrangement and E2A-PBX1 fusion. Its overexpression supports tumorigenicity by maintaining the repression of genes involved in cell cycle regulation and differentiation (Fan2020BAHCC1). Mutations in the BAH module of BAHCC1, such as Y2533A and W2554G, disrupt its interaction with the H3K27me3 mark, leading to derepression of genes typically silenced by Polycomb Repressive Complexes, affecting cell cycle progression and proliferation in leukemia cells (Fan2020BAHCC1).

In melanoma, BAHCC1 expression is driven by super-enhancers and is associated with poor patient survival. It regulates genes involved in cell cycle and DNA repair, and its knockdown reduces melanoma cell proliferation and enhances the effects of MAPKi and PARP inhibitors, suggesting its potential as a therapeutic target (Berico2023Superenhancer). These findings highlight the clinical significance of BAHCC1 in cancer, where its altered expression or mutations can contribute to oncogenesis.

## Interactions
The BAHCC1 protein is involved in several interactions that play a crucial role in gene silencing and oncogenesis. It specifically binds to the H3K27me3 histone mark through its BAH domain, a critical interaction for maintaining a hypoacetylated chromatin state at target genes. This interaction is facilitated by the formation of a deep pocket with mixed aromatic and acidic residues, allowing BAHCC1 to recognize H3K27me3 via a cavity insertion mechanism (Fan2020BAHCC1).

BAHCC1 also interacts with transcriptional corepressors, including HDAC1 and SAP30BP, which are part of the histone deacetylase (HDAC) complexes. These interactions help maintain gene silencing by promoting hypoacetylation at target genes (Fan2020BAHCC1). Mass spectrometry and co-immunoprecipitation studies have confirmed these interactions in HeLa and JURKAT cells (Fan2020BAHCC1).

In addition, BAHCC1 interacts with BRG1-containing complexes, which are part of the PBAF chromatin remodeling complex. This interaction is mediated by the BAH domain and regulates genes involved in DNA repair and cell cycle processes (Berico2023Superenhancer). These interactions highlight BAHCC1's role in chromatin organization and transcriptional regulation.


## References


1. (Berico2023Superenhancer) Super-enhancer driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability. This article has 0 citations.

[2. (Fan2020BAHCC1) Huitao Fan, Jiuwei Lu, Yiran Guo, Dongxu Li, Zhi-Min Zhang, Yi-Hsuan Tsai, Wen-Chieh Pi, Jeong Hyun Ahn, Weida Gong, Yu Xiang, David F. Allison, Huimin Geng, Shenghui He, Yarui Diao, Wei-Yi Chen, Brian D. Strahl, Ling Cai, Jikui Song, and Gang Greg Wang. Bahcc1 binds h3k27me3 via a conserved bah module to mediate gene silencing and oncogenesis. Nature Genetics, 52(12):1384â€“1396, November 2020. URL: http://dx.doi.org/10.1038/s41588-020-00729-3, doi:10.1038/s41588-020-00729-3. This article has 62 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41588-020-00729-3)